{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:46:19Z","timestamp":1792086379745,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016990","name":"Hellenic Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010353","name":"Hellenic Atherosclerosis Society","doi-asserted-by":"publisher","award":["2022\\u20132025"],"award-info":[{"award-number":["2022\\u20132025"]}],"id":[{"id":"10.13039\/501100010353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.annepidem.2025.09.007","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T07:01:27Z","timestamp":1757660487000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cardiovascular disease burden attributable to estimated glomerular filtration rate: Insights from the ATTICA study (2002\u20132022)"],"prefix":"10.1016","volume":"111","author":[{"given":"Evangelia","family":"Damigou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Florentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Chrysohoou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Barkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Liberopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Pitsavos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8583-153X","authenticated-orcid":false,"given":"Demosthenes","family":"Panagiotakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2025.09.007_bib1","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","article-title":"An update on the global disparities in kidney disease burden and care across world countries and regions","volume":"12","author":"Bello","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.annepidem.2025.09.007_bib2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication\u2014worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.annepidem.2025.09.007_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"2013 mortality and causes of death collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the global burden of disease study 2013","volume":"385","author":"GBD","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2025.09.007_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064540","article-title":"Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the global burden of disease study 2019","volume":"13","author":"Feng","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.annepidem.2025.09.007_bib5","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"issue":"2011","key":"10.1016\/j.annepidem.2025.09.007_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.annepidem.2025.09.007_bib7","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","article-title":"Global economic burden associated with chronic kidney disease: a pragmatic review of medical costs for the inside CKD research programme","volume":"40","author":"Jha","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.annepidem.2025.09.007_bib8","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.annepidem.2025.09.007_bib9","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","author":"Global Cardiovascular Risk Consortium","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2025.09.007_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annepidem.2023.09.010","article-title":"Prediction of lifetime risk for cardiovascular disease, by risk factors level: the ATTICA epidemiological cohort study (2002\u20132022)","volume":"87","author":"Panagiotakos","year":"2023","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib11","unstructured":"American Heart Association. Life\u2019s essential 8. WwwHeartOrg; n.d. \u3008https:\/\/www.heart.org\/en\/healthy-living\/healthy-lifestyle\/lifes-essential-8\u3009 [Accessed 1 October 2023]."},{"key":"10.1016\/j.annepidem.2025.09.007_bib12","first-page":"zwae279","article-title":"Obesity and cardiovascular disease: an ESC clinical consensus statement","author":"Koskinas","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.clnu.2024.02.006","article-title":"Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: the ATTICA cohort study (2002\u20132022)","volume":"43","author":"Kouvari","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.annepidem.2025.09.007_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100552","article-title":"Incorporating kidney disease measures into cardiovascular risk prediction: development and validation in 9 million adults from 72 datasets","volume":"27","author":"Matsushita","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.annepidem.2025.09.007_bib16","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.annepidem.2025.09.007_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.annepidem.2020.12.004","article-title":"Urinary albumin-to-creatinine ratio within normal range and all-cause or cardiovascular mortality among U.S. adults enrolled in the NHANES during 1999\u20132015","volume":"55","author":"Inoue","year":"2021","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/CIRCULATIONAHA.124.068242","article-title":"Kidney disease as a cardiovascular disease priority","volume":"150","author":"Kotwal","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.annepidem.2025.09.007_bib19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.annepidem.2025.09.007_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.annepidem.2011.01.007","article-title":"Subclinical atherosclerotic changes related to chronic kidney disease in asymptomatic black and white young adults: the Bogalusa Heart Study","volume":"21","author":"Dasmahapatra","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2458-3-32","article-title":"Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study","volume":"3","author":"Pitsavos","year":"2003","journal-title":"BMC Public Health"},{"key":"10.1016\/j.annepidem.2025.09.007_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijcard.2014.11.206","article-title":"Ten-year (2002\u20132012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: the ATTICA study","volume":"180","author":"Panagiotakos","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3390\/life13051142","article-title":"Lifestyle trajectories are associated with incidence of cardiovascular disease: highlights from the ATTICA epidemiological cohort study (2002\u20132022)","volume":"13","author":"Damigou","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.annepidem.2025.09.007_bib24","first-page":"388","article-title":"Prevalence and five-year incidence (2001\u20132006) of cardiovascular disease risk factors in a Greek sample: the ATTICA study","volume":"50","author":"Panagiotakos","year":"2009","journal-title":"Hell J Cardiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib25","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-Based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2025.09.007_bib26","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"KDIGO","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.annepidem.2025.09.007_bib27","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/dc09-1825","article-title":"Visceral adiposity index","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.annepidem.2025.09.007_bib28","first-page":"283","article-title":"Reliability measures of the short international physical activity questionnaire (IPAQ) in Greek young adults","volume":"50","author":"Papathanasiou","year":"2009","journal-title":"Hell J Cardiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib29","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/ije\/26.suppl_1.S118","article-title":"Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers","volume":"26","author":"Katsouyanni","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.numecd.2005.08.006","article-title":"Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk","volume":"16","author":"Panagiotakos","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.annepidem.2025.09.007_bib31","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/CIRCULATIONAHA.122.060700","article-title":"Mild-to-moderate kidney dysfunction and cardiovascular disease: observational and mendelian randomization analyses","volume":"146","author":"Gaziano","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.annepidem.2025.09.007_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.aje.a121617","article-title":"Proportion of disease caused or prevented by a given exposure, trait or intervention","volume":"99","author":"Miettinen","year":"1974","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2025.09.007_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12882-023-03056-x","article-title":"Prevalence and incidence of chronic kidney disease stage 3\u20135 \u2013 results from KidDiCo","volume":"24","author":"Kampmann","year":"2023","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib35","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/s41598-025-86030-x","article-title":"The association between metabolomic profiles of lifestyle and the latent phase of incident chronic kidney disease in the UK population","volume":"15","author":"Jin","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.annepidem.2025.09.007_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijcard.2008.11.131","article-title":"Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome","volume":"141","author":"Maurer","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2024.107869","article-title":"Impaired kidney function and the risk of all-cause mortality and cardiovascular disease among Chinese hypertensive adults: using three different equations to estimate the glomerular filtration rate","volume":"180","author":"Wang","year":"2024","journal-title":"Prev Med"},{"key":"10.1016\/j.annepidem.2025.09.007_bib38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cjco.2022.06.011","article-title":"Cardiorenal interactions: a review","volume":"4","author":"Verma","year":"2022","journal-title":"CJC Open"},{"key":"10.1016\/j.annepidem.2025.09.007_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000346817","article-title":"Preclinical cardiorenal interrelationships in essential hypertension","volume":"3","author":"Tsioufis","year":"2013","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.annepidem.2025.09.007_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjcard.2024.05.001","article-title":"Cardiovascular and renal benefit of sodium-glucose cotransporter type 2 inhibitors in patients with type 2 diabetes","volume":"223","author":"Lam","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.annepidem.2025.09.007_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2023.107763","article-title":"Age-dependent interaction between life\u2019s essential 8 and chronic kidney disease: a national cross-sectional analysis","volume":"177","author":"Zhang","year":"2023","journal-title":"Prev Med"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279725002625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279725002625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:50:36Z","timestamp":1773111036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279725002625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"alternative-id":["S1047279725002625"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2025.09.007","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease burden attributable to estimated glomerular filtration rate: Insights from the ATTICA study (2002\u20132022)","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2025.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}